Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 86
Filter
1.
Acad Radiol ; 2024 May 03.
Article in English | MEDLINE | ID: mdl-38704282
2.
Sci Rep ; 13(1): 14895, 2023 09 09.
Article in English | MEDLINE | ID: mdl-37689744

ABSTRACT

We evaluate stability of spectral results at different heart rates, acquisition modes, and cardiac phases in first-generation clinical dual-source photon-counting CT (PCCT). A cardiac motion simulator with a coronary stenosis mimicking a 50% eccentric calcium plaque was scanned at five different heart rates (0, 60-100 bpm) with the three available cardiac scan modes (high pitch prospectively ECG-triggered spiral, prospectively ECG-triggered axial, retrospectively ECG-gated spiral). Subsequently, full width half max (FWHM) of the stenosis, Dice score (DSC) for the stenosed region, and eccentricity of the non-stenosed region were calculated for virtual monoenergetic images (VMI) at 50, 70, and 150 keV and iodine density maps at both diastole and systole. FWHM averaged differences of - 0.20, - 0.28, and - 0.15 mm relative to static FWHM at VMI 150 keV across acquisition parameters for high pitch prospectively ECG-triggered spiral, prospectively ECG-triggered axial, and retrospectively ECG-gated spiral scans, respectively. Additionally, there was no effect of heart rate and acquisition mode on FWHM at diastole (p-values < 0.001). DSC demonstrated similarity among parameters with standard deviations of 0.08, 0.09, 0.11, and 0.08 for VMI 50, 70, and 150 keV, and iodine density maps, respectively, with insignificant differences at diastole (p-values < 0.01). Similarly, eccentricity illustrated small differences across heart rate and acquisition mode for each spectral result. Consistency of spectral results at different heart rates and acquisition modes for different cardiac phase demonstrates the added benefit of spectral results from PCCT to dual-source CT to further increase confidence in quantification and advance cardiovascular diagnostics.


Subject(s)
Coronary Stenosis , Iodine , Humans , Retrospective Studies , Tomography, X-Ray Computed , Heart/diagnostic imaging , Constriction, Pathologic
4.
Ann Biomed Eng ; 49(2): 585-600, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32785862

ABSTRACT

Despite great efforts, transoral robotic laser surgery has not been established clinically. Patient benefits are yet to be proven to accept shortcomings of robotic systems. In particular, laryngeal reachability and transition from microscope to accurate endoscopic laser ablation have not been achieved. We have addressed those challenges with a highly integrated robotic endoscope for non-contact endolaryngeal laser surgery. The current performance status has been assessed in multi-level user studies. In addition, the system was deployed to an ex vivo porcine larynx. The robotic design comprises an extensible continuum manipulator with multifunctional tip. The latter features laser optics, stereo vision, and illumination. Vision-based performance assessment is derived from depth estimation and scene tracking. Novices and experts (n = 20) conducted teleoperated delineation tasks to mimic laser ablation of delicate anatomy. Delineation with motion-compensated and raw endoscopic visualisation was carried out on planar and non-planar nominal patterns. Root mean square tracing errors of less than 0.75 mm were feasible with task completion times below 45 s. Relevant anatomy in the porcine larynx was exposed successfully. Accuracy and usability of the integrated platform bear potential for dexterous laser manipulation in clinical settings. Cadaver and in vivo animal studies may translate ex vivo findings.


Subject(s)
Laryngoscopes , Laryngoscopy/instrumentation , Larynx/surgery , Laser Therapy/instrumentation , Robotic Surgical Procedures/instrumentation , Adult , Animals , Equipment Design , Female , Humans , Male , Models, Biological , Swine
5.
J Am Coll Radiol ; 2020 Oct 13.
Article in English | MEDLINE | ID: mdl-33065074

ABSTRACT

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

7.
Med Klin Intensivmed Notfmed ; 114(8): 708-716, 2019 Nov.
Article in German | MEDLINE | ID: mdl-30232503

ABSTRACT

BACKGROUND: Bradykinin-mediated, drug-induced edema like ACE-inhibitor-induced angioedema (ACEi AE) is almost exclusively located in the head and neck region and is potentially life threatening. To date, there are no guidelines or officially-approved treatments available for this pathology. OBJECTIVES: We sought to provide a structured therapeutic algorithm for the acute treatment of drug-induced bradykinin-mediated angioedema. MATERIALS AND METHODS: We analyzed data (especially the course of disease and therapy) of all patients with acute angioedema, who presented to the Department of Otorhinolaryngology, Head and Neck Surgery at the University of Ulm (2010-2015). We also conducted a literature review on PubMed with the terms "acute angioedema", "angioedema emergency", "ACE angioedema", "bradykinin angioedema" and "angioedema therapy". Other fundamental references were the recent German guidelines "hereditary angioedema", "anaphylaxis" and "airway management". RESULTS: An emergency algorithm was generated as a flowchart for the acute therapy of bradykinin-mediated drug-induced angioedema was generated. We focused on the decision criteria for intubation/airway management and pharmacological therapy: antihistamines and glucocorticoids versus anti-bradykinin treatment. Furthermore, recommendations for inpatient monitoring have been derived. CONCLUSION/DISCUSSION: To date, therapy of drug-induced bradykinin-mediated angioedema is performed according to an "off-label" use and without officially-approved guidelines. The presented emergency algorithm provides a first approach for a structured therapeutic concept for a potentially life-threatening pathology.


Subject(s)
Angioedema , Bradykinin B2 Receptor Antagonists/therapeutic use , Bradykinin , Practice Guidelines as Topic , Airway Management , Algorithms , Angioedema/chemically induced , Angioedema/drug therapy , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Bradykinin/adverse effects , Humans
8.
Eur Radiol ; 28(12): 5069-5075, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29869174

ABSTRACT

PURPOSE: CT perfusion (CTP) imaging assessment of treatment response in advanced lung cancer can be compromised by respiratory motion. Our purpose was to determine whether an original motion correction method could improve the reproducibility of such measurements. MATERIALS AND METHODS: The institutional review board approved this prospective study. Twenty-one adult patients with non-resectable non-small-cell lung cancer provided written informed consent to undergo CTP imaging. A motion correction method that consisted of manually outlining the tumor margins and then applying a rigid manual landmark registration algorithm followed by the non-rigid diffeomorphic demons algorithm was applied. The non-motion-corrected and motion-corrected images were analyzed with dual blood supply perfusion analysis software. Two observers performed the analysis twice, and the intra- and inter-observer variability of each method was assessed with Bland-Altman statistics. RESULTS: The 95% limits of agreement of intra-observer reproducibility for observer 1 improved from -84.4%, 65.3% before motion correction to -33.8%, 30.3% after motion correction (r = 0.86 and 0.97, before and after motion correction, p < 0.0001 for both) and for observer 2 from -151%, 96% to -49 %, 36 % (r = 0.87 and 0.95, p < 0.0001 for both). The 95% limits of agreement of inter-observer reproducibility improved from -168%, 154% to -17%, 25%. CONCLUSION: The use of a motion correction method significantly improves the reproducibility of CTP estimates of tumor blood flow in lung cancer. KEY POINTS: • Tumor blood flow estimates in advanced lung cancer show significant variability. • Motion correction improves the reproducibility of CT blood flow estimates in advanced lung cancer. • Reproducibility of blood flow measurements is critical to characterize lung tumor biology and the success of treatment in lung cancer.


Subject(s)
Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Lung Neoplasms/diagnostic imaging , Neovascularization, Pathologic/diagnostic imaging , Adult , Aged , Algorithms , Carcinoma, Non-Small-Cell Lung/blood supply , Carcinoma, Non-Small-Cell Lung/physiopathology , Female , Humans , Lung Neoplasms/blood supply , Lung Neoplasms/physiopathology , Male , Middle Aged , Motion , Neovascularization, Pathologic/physiopathology , Observer Variation , Perfusion Imaging/methods , Prospective Studies , Radiographic Image Interpretation, Computer-Assisted/methods , Reproducibility of Results , Respiration , Software , Tomography, X-Ray Computed/methods
9.
Int J Med Robot ; 14(5): e1928, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29923349

ABSTRACT

BACKGROUND: Evidence suggests that transoral robot-assisted surgery is becoming increasingly common, yet current systems are incapable of sufficiently reaching the glottis or subglottic areas. This paper presents a teleoperated tubular continuum robot prototype for laryngeal surgery in a feasibility study. METHODS: A tubular continuum robot prototype is used to perform basic surgical examination in five ex vivo porcine laryngeal specimens. Standard imaging and tooling were integrated and evaluated to improve the system for future application in humans. RESULTS: Access to and application of the tubular continuum robot in the porcine larynx is feasible. Visualization of and accessibility to all structures of interest were successfully achieved, and minor surgical procedures such as biopsies could be performed. CONCLUSIONS: Despite proven feasibility, there is a need for further improvements. A version with dual robot arms would be essential to realize a pre-market prototype for further investigation in a human model.


Subject(s)
Larynx/surgery , Robotic Surgical Procedures/methods , Animals , Feasibility Studies , Models, Animal , Swine
10.
J Neurol Surg B Skull Base ; 78(6): 466-472, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29134165

ABSTRACT

Objective Advanced transnasal sinus and skull base surgery remains a challenging discipline for head and neck surgeons. Restricted access and space for instrumentation can impede advanced interventions. Thus, we present the combination of an innovative robotic endoscope guidance system and a specific endoscope with adjustable viewing angle to facilitate transnasal surgery in a human cadaver model. Materials and Methods The applicability of the robotic endoscope guidance system with custom foot pedal controller was tested for advanced transnasal surgery on a fresh frozen human cadaver head. Visualization was enabled using a commercially available endoscope with adjustable viewing angle (15-90 degrees). Results Visualization and instrumentation of all paranasal sinuses, including the anterior and middle skull base, were feasible with the presented setup. Controlling the robotic endoscope guidance system was effectively precise, and the adjustable endoscope lens extended the view in the surgical field without the common change of fixed viewing angle endoscopes. Conclusion The combination of a robotic endoscope guidance system and an advanced endoscope with adjustable viewing angle enables bimanual surgery in transnasal interventions of the paranasal sinuses and the anterior skull base in a human cadaver model. The adjustable lens allows for the abandonment of fixed-angle endoscopes, saving time and resources, without reducing the quality of imaging.

11.
HNO ; 64(9): 658-66, 2016 Sep.
Article in German | MEDLINE | ID: mdl-27510228

ABSTRACT

Robot-assisted surgery (RAS) in the head and neck region is believed to have a large potential for the improvement of patient care. Several systems with a master-slave setup are already in routine clinical use, particularly for oncologic surgery. Although specific patient groups may benefit from RAS, there is a lack of randomized clinical studies validating the advantages of these new technological systems in comparison to the existing standard procedures. On the other hand, RAS in the head and neck region is being constantly developed. Currently, the main limitations are the technical miniaturization of the tools and the loss of haptic feedback, as well as the high costs for acquisition and maintenance without financial reimbursement. In any case, the current generation of head and neck surgeons will face the technical, scientific, and ethical challenges of RAS.


Subject(s)
Head and Neck Neoplasms/surgery , Head/surgery , Neck/surgery , Otorhinolaryngologic Surgical Procedures/methods , Robotic Surgical Procedures/methods , Evidence-Based Medicine , Head and Neck Neoplasms/diagnostic imaging , Humans , Otorhinolaryngologic Surgical Procedures/instrumentation , Otorhinolaryngologic Surgical Procedures/trends , Robotic Surgical Procedures/instrumentation , Robotic Surgical Procedures/trends , Technology Assessment, Biomedical , Treatment Outcome
12.
Clin Exp Immunol ; 185(2): 219-27, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27163159

ABSTRACT

The predisposition of preterm neonates to invasive infection is, as yet, incompletely understood. Regulatory T cells (Tregs ) are potential candidates for the ontogenetic control of immune activation and tissue damage in preterm infants. It was the aim of our study to characterize lymphocyte subsets and in particular CD4(+) CD25(+) forkhead box protein 3 (FoxP3)(+) Tregs in peripheral blood of well-phenotyped preterm infants (n = 117; 23 + 0 - 36 + 6 weeks of gestational age) in the first 3 days of life in comparison to term infants and adults. We demonstrated a negative correlation of Treg frequencies and gestational age. Tregs were increased in blood samples of preterm infants compared to term infants and adults. Notably, we found an increased Treg frequency in preterm infants with clinical early-onset sepsis while cause of preterm delivery, e.g. chorioamnionitis, did not affect Treg frequencies. Our data suggest that Tregs apparently play an important role in maintaining maternal-fetal tolerance, which turns into an increased sepsis risk after preterm delivery. Functional analyses are needed in order to elucidate whether Tregs have potential as future target for diagnostics and therapeutics.


Subject(s)
Infant, Premature, Diseases/immunology , Infant, Premature/immunology , Sepsis/immunology , T-Lymphocytes, Regulatory/immunology , Adult , Amnion/microbiology , Chorioamnionitis/immunology , Female , Forkhead Transcription Factors/blood , Gestational Age , Humans , Immune Tolerance , Infant , Infant, Newborn , Lymphocyte Subsets/cytology , Lymphocyte Subsets/immunology , Pregnancy , Sepsis/microbiology
13.
Int J Tuberc Lung Dis ; 18(8): 952-7, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25199010

ABSTRACT

SETTING: Cytokines play an important role in anti-tuberculosis immune response, combined with antigen-presenting cells and lymphocytes. Immune response gene polymorphisms have been reported to be associated with tuberculosis (TB) susceptibility in some but not all studies. OBJECTIVE: To evaluate the association of immune response genes with susceptibility to tuberculin skin test (TST) reactivity and/or TB. DESIGN: Fourteen single nucleotide polymorphisms were genotyped in 96 individuals of the Aché, a native Paraguayan population, by allelic discrimination using real-time polymerase chain reaction. Univariate and multivariate Poisson regression were employed to assess risk genotypes. RESULTS: A higher prevalence of purified protein derivative reactivity was associated with the TNF-α CCA/TCG haplotype (PR 1.298, 95%CI 1.059-1.589) and with the IL-10 AT/CC diplotype (PR 1.181, 95% CI 1.024-1.362), and the presence of the IL-8 rs4073 T allele was associated with protection against TB (PR 0.482, 95%CI 0.273-0.851). CONCLUSIONS: These results suggest that polymorphisms in genes associated with immune response are involved in TST reactivity and susceptibility to TB in the Aché population.


Subject(s)
Interleukin-10/genetics , Interleukin-8/genetics , Tuberculosis/epidemiology , Tumor Necrosis Factor-alpha/genetics , Adult , Case-Control Studies , Female , Genetic Predisposition to Disease , Genotype , Humans , Indians, South American/genetics , Male , Middle Aged , Multivariate Analysis , Paraguay , Poisson Distribution , Polymorphism, Single Nucleotide , Real-Time Polymerase Chain Reaction , Regression Analysis , Tuberculin Test , Tuberculosis/genetics , Tuberculosis/immunology , Young Adult
14.
Clin Lung Cancer ; 15(2): 103-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24361250

ABSTRACT

INTRODUCTION: We set out to investigate whether volumetric tumor measurements allow for a prediction of treatment response, as measured by patient survival, in patients with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: Patients with nonresectable NSCLC (stage III or IV, n = 100) who were repeatedly evaluated for treatment response by computed tomography (CT) were included in a Health Insurance Portability and Accountability Act (HIPAA)-compliant retrospective study. Tumor response was measured by comparing tumor volumes over time. Patient survival was compared with Response Evaluation Criteria in Solid Tumors (RECIST) using Kaplan-Meier survival statistics and Cox regression analysis. RESULTS: The median overall patient survival was 553 days (standard error, 146 days); for patients with stage III NSCLC, it was 822 days, and for patients with stage IV disease, 479 days. The survival differences were not statistically significant (P = .09). According to RECIST, 5 patients demonstrated complete response, 39 partial response, 44 stable disease, and 12 progressive disease. Patient survival was not significantly associated with RECIST class, the change of the sum of tumor diameters (P = .98), nor the change of the sum of volumetric tumor dimensions (P = .17). CONCLUSION: In a group of 100 patients with advanced-stage NSCLC, neither volumetric CT measurements of changes in tumor size nor RECIST class significantly predicted patient survival. This observation suggests that size response may not be a sufficiently precise surrogate marker of success to steer treatment decisions in individual patients.


Subject(s)
Adenocarcinoma/pathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Squamous Cell/pathology , Lung Neoplasms/pathology , Tomography, X-Ray Computed/methods , Tumor Burden , Adenocarcinoma/drug therapy , Adenocarcinoma/mortality , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/mortality , Follow-Up Studies , Health Insurance Portability and Accountability Act , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/mortality , Neoplasm Staging , Prognosis , Retrospective Studies , Survival Rate , United States
15.
Eur J Radiol ; 82(12): 2392-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24120225

ABSTRACT

OBJECTIVES: To determine if measurements of aortic wall attenuation can improve the CT diagnosis of acute aortic syndromes. METHODS: CT reports from a ten year period were searched for acute aortic syndromes (AAS). Studies with both an unenhanced and a contrast enhanced (CTA) series that had resulted in the diagnosis of intramural hematoma (IMH) were reviewed. Diagnoses were confirmed by medical records. The attenuation of aortic wall abnormalities was measured. The observed attenuation threshold was validated using studies from 39 new subjects with a variety of aortic conditions. RESULTS: The term "aortic dissection" was identified in 1206, and IMH in 124 patients' reports. IMH was confirmed in 31 patients, 21 of whom had both unenhanced and contrast enhanced images. All 21 had pathologic CTA findings, and no CTA with IMH was normal. Attenuation of the aortic wall was greater than 45 HUs on the CTA images in all patients with IMH. When this threshold was applied to the new group, sensitivity for diagnosing AAS was 100% (19/19), and specificity 94% (16/17). Addition of unenhanced images did not improve accuracy. CONCLUSIONS: Measurements of aortic wall attenuation in CTA have a high negative predictive value for the diagnosis of acute aortic syndromes.


Subject(s)
Aortic Aneurysm/diagnostic imaging , Aortic Dissection/diagnostic imaging , Aortography/methods , Atherosclerosis/diagnostic imaging , Hematoma/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Acute Disease , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Radiographic Image Interpretation, Computer-Assisted/standards , Reproducibility of Results , Sensitivity and Specificity , Syndrome , Tomography, X-Ray Computed/standards , Young Adult
16.
Arch Pathol Lab Med ; 136(12): 1552-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23194048

ABSTRACT

CONTEXT: The causes of death for patients with lung cancer are inadequately described. OBJECTIVE: To categorize the immediate and contributing causes of death for patients with lung cancer. DESIGN: The autopsies from 100 patients who died of lung cancer between 1990 and February 2011 were analyzed. RESULTS: Tumor burden was judged the immediate cause of death in 30 cases, including 26 cases of extensive metastases and 4 cases with wholly or primarily lung tumor burden (causing respiratory failure). Infection was the immediate cause of death for 20 patients, including 8 with sepsis and 12 with pneumonia. Complications of metastatic disease were the immediate causes of death in 18 cases, including 6 cases of hemopericardium from pericardial metastases, 3 from myocardial metastases, 3 from liver metastases, and 3 from brain metastases. Other immediate causes of death were pulmonary hemorrhage (12 cases), pulmonary embolism (10 cases, 2 tumor emboli), and pulmonary diffuse alveolar damage (7 cases). From a functional (pathophysiologic) perspective, respiratory failure could be regarded as the immediate cause of death (or mechanism of death) in 38 cases, usually because of a combination of lung conditions, including emphysema, airway obstruction, pneumonia, hemorrhage, embolism, resection, and lung injury in addition to the tumor. For 94 of the 100 patients, there were contributing causes of death, with an average of 2.5 contributing causes and up to 6 contributing causes of death. CONCLUSIONS: The numerous and complex ways lung cancer kills patients pose a challenge for efforts to extend and improve their lives.


Subject(s)
Lung Neoplasms/mortality , Academic Medical Centers , Adult , Aged , Aged, 80 and over , Autopsy , Brain Neoplasms/mortality , Brain Neoplasms/secondary , Cause of Death , Electronic Health Records , Female , Heart Neoplasms/mortality , Heart Neoplasms/pathology , Heart Neoplasms/secondary , Humans , Liver Neoplasms/mortality , Liver Neoplasms/secondary , Lung Neoplasms/complications , Lung Neoplasms/pathology , Lung Neoplasms/physiopathology , Male , Middle Aged , Pennsylvania/epidemiology , Pericardial Effusion/complications , Pericardial Effusion/mortality , Pericardium/pathology , Pneumonia/complications , Pneumonia/mortality , Respiratory Insufficiency/complications , Respiratory Insufficiency/etiology , Respiratory Insufficiency/mortality , Sepsis/complications , Sepsis/mortality , Tumor Burden
17.
Placenta ; 32(11): 830-7, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21899884

ABSTRACT

The placenta is a major barrier that prevents potentially infectious agents from causing fetal diseases or related complications during pregnancy. Therefore, we postulated that the placenta might express a broad repertoire of antimicrobial proteins as well as inflammatory chemokines and cytokines to combat invading microorganisms. Here we demonstrate that placental cells indeed express a wide range of AMPs (antimicrobial peptides and proteins) including bactericidal/permeability-increasing protein (BPI), secretory leukocyte protease inhibitor (SLPI), human ß-defensin 2 (hBD2), acyloxyacyl hydrolase (AOAH), and cathelicidin (CAP18). In addition, these cells also secrete pro-inflammatory cytokines and chemokines upon stimulation with bacterial ligands. Notably, we show that BPI expression by placental cells could be completely attributed to granulocytes while highly purified placental trophoblasts expressed only a subset of the AMPs like SLPI. Unexpectedly, trophoblast AMPs did not exhibit inducible secretion in response to various TLR ligands and further investigations showed that the unresponsiveness of trophoblasts to lipopolysaccharide (LPS) was due to a lack of TLR4 expression. In summary, we have shown that the expression of different AMPs can be allocated to various cells in the placenta and the repertoire of the AMPs expressed by placental cells is a result of a cooperation of leukocytes as well as cells from embryonic origin.


Subject(s)
Antimicrobial Cationic Peptides/genetics , Placenta/cytology , Placenta/physiology , alpha-Defensins/genetics , Antimicrobial Cationic Peptides/metabolism , Cells, Cultured , Cytokines/metabolism , Female , Gene Expression Profiling , Gene Expression Regulation , Humans , Organ Specificity , Placenta/immunology , Placenta/metabolism , Pregnancy , Trophoblasts/cytology , Trophoblasts/metabolism , Trophoblasts/physiology , Up-Regulation , alpha-Defensins/metabolism
18.
Opt Lett ; 36(14): 2746-8, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21765529

ABSTRACT

All-reflective optical systems are under consideration for future gravitational wave detector topologies. A key feature of these all-reflective systems is the use of Fabry-Perot cavities with diffraction gratings as input couplers; however, theory predicts and experiment has shown that translation of the grating surface across the incident laser light will introduce additional phase into the system. This translation can be induced through simple side-to-side motion of the coupler, yaw motion of the coupler around a central point (i.e., rotation about a vertical axis), and even via internal resonances (i.e., vibration) of the optical element. In this Letter we demonstrate on a prototype-scale suspended cavity that conventional cavity length-sensing techniques used to detect longitudinal changes along the cavity axis will also be sensitive to translational, rotational, and vibrational motion of the diffractive input coupler. We also experimentally verify the amplitude response and frequency dependency of the noise coupling as given by theory.

19.
Klin Padiatr ; 223(1): 10-4, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21271514

ABSTRACT

BACKGROUND: During a period of 12 months 7 newborns with a partially severe fetopathy caused most probably by maternal sartan-intake in pregnancy were treated in 5 German teaching hospitals. Sartans antagonize the effect of angiotensin II at the AT1-receptor and are used to treat arterial hypertension. METHOD: We presented 2 cases at the yearly GNPI meeting 2010 and we were informed about similar cases in other German teaching hospitals which we brought together in this publication. RESULTS: In the presented cases, maternal sartan intake was noticed at different times in pregnancy and was in part discontinued some weeks before delivery. In all pregnancies oligohydramnios was present and fetal kidneys displayed a hyperechogenic structure on ultrasound. The newborns' postnatal course varied: oligohydramnios sequence with lung hypoplasia, arterial hypotension and renal insufficiency were the predominant problems of the first days of life. The majority (4/7) of infants did not survive this period, in other cases there was a complete (1/7) recovery of renal function whereas others survived with renal impairment (2/7), in part requiring chronic dialysis. Further distinctive features seen frequently were disturbances of cranial ossification and flaccid paralysis of hands and feet with deviations as well as sensorineural hearing loss. CONCLUSION: These case reports again underline the hazardousness of maternal sartan intake with potential fatal outcome for the newborn. Though the use of sartans in pregnancy is contraindicated and several case reports of sartan induced fetopathies exist, the risk of sartan treatment generally seems to be underestimated.


Subject(s)
Abnormalities, Drug-Induced/etiology , Angiotensin II Type 1 Receptor Blockers/toxicity , Antihypertensive Agents/toxicity , Hypertension, Pregnancy-Induced/drug therapy , Abnormalities, Drug-Induced/diagnosis , Abnormalities, Drug-Induced/pathology , Adult , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Antihypertensive Agents/therapeutic use , Apgar Score , Benzimidazoles/therapeutic use , Benzimidazoles/toxicity , Biphenyl Compounds , Female , Fetal Growth Retardation/chemically induced , Fetal Growth Retardation/diagnosis , Fetal Growth Retardation/pathology , Humans , Hypertension, Pulmonary/chemically induced , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/pathology , Imidazoles/therapeutic use , Imidazoles/toxicity , Infant, Newborn , Kidney/abnormalities , Kidney/drug effects , Kidney/pathology , Lung/abnormalities , Lung/drug effects , Lung/pathology , Male , Oligohydramnios/chemically induced , Pregnancy , Pregnancy Trimester, Second , Pregnancy Trimester, Third , Renal Insufficiency/chemically induced , Renal Insufficiency/diagnosis , Renal Insufficiency/pathology , Skull/abnormalities , Skull/drug effects , Skull/pathology , Tetrazoles/therapeutic use , Tetrazoles/toxicity , Ultrasonography, Prenatal , Valine/analogs & derivatives , Valine/therapeutic use , Valine/toxicity , Valsartan
20.
Int J STD AIDS ; 21(9): 611-6, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21097732

ABSTRACT

Herpes simplex virus type 2 (HSV-2) is a risk factor for HIV-1 infection. We characterized HSV-2 serology assay performance in HIV-positive and HIV-negative Africans. Serostatus for HSV-2 and HIV-1 was determined in 493 serum specimens stored from a community HSV-2 prevalence survey in Kampala, Uganda. HSV-2 serology by Focus HerpeSelect ELISA, Biokit HSV-2 rapid assay and Kalon HSV-2 was compared with HSV-2 Western blot (WB) according to HIV-1 serostatus. Sensitivity/specificity was: 99.5%/70.2% for Focus, 97.0%/86.4% for Biokit and 97.5%/96.2% for Kalon. Focus with Biokit confirmation improved sensitivity/specificity (99.4%/96.8%, respectively). Use of a higher Focus index value cut-off of 2.2 instead of 1.1 increased specificity from 70.2% to 92.4%. Kalon had higher specificity than Focus (P < 0.001). Of commercially available HSV-2 serological assays, Kalon alone, or Focus ELISA followed by Biokit confirmation perform best. Improved HSV-2 assays are needed for HSV-2 and HIV-1 public health activities in Africa.


Subject(s)
Antibodies, Viral/blood , Herpes Simplex/diagnosis , Herpesvirus 2, Human/immunology , Virology/methods , Adult , Female , HIV Infections/diagnosis , Herpes Simplex/complications , Herpesvirus 2, Human/isolation & purification , Humans , Immunoassay/methods , Male , Reagent Kits, Diagnostic , Sensitivity and Specificity , Uganda
SELECTION OF CITATIONS
SEARCH DETAIL
...